Change over period: —
NSE · ALBERTDAVD
ALBERTDAVD
-15.4% from the 52-week high · +29.4% above the low
Albert David Ltd. engages in the manufacturing and trade of pharmaceuticals. The company is headquartered in Kolkata, West Bengal and currently employs 1,271 full-time employees. The company went IPO on 2016-06-14. The firm offers its products under various categories, which includes parenterals, oral/enteral, topical agents and vision care. Its parenterals consists of amino acids infusion, antimicrobial, anti-leishmaniasis (kalazar), hemostat, neurotropic vitamin and placenta extract. Its oral/enteral consists of amino acids oral, anthelmintic, anti-microbial, anti ulcerants, anti-vertigo, appetite stimulants, anti-tubercular, haematinics, oral vitamin b complex and expectorant / cough syrup. Its topical agents consist of non-steroidal anti-inflammatory drugs (NSAID). Its vision care consists of anti-glaucoma, anti-infective, tear substitutes and anti-infective with NSAID. The firm's plants are located at Gupta Lane, Kolkata and Meerut Road, Industrial Area, Ghaziabad.
The short version. Promoter holding was 62.24% in Sep 2026, up 0.11 points over 8 quarters.
1 · The price
How has the stock traded?
ALBERTDAVD trades 15.4% below its 52-week high and 29.4% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Up 0.11 pts over 8 quarters.
Down 0.26 pts over 8 quarters.
Unchanged over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 62.13 | 62.24 | 62.24 | 62.24 | 62.24 | 62.24 | 62.24 | 62.24 | +0.11 |
| FII | 0.86 | 1.01 | 0.84 | 0.6 | 0.6 | 0.58 | 0.57 | 0.6 | -0.26 |
| DII | 1.64 | 1.65 | 1.66 | 1.66 | 1.66 | 1.66 | 1.64 | 1.64 | 0.0 |
| Public | 35.37 | 35.11 | 35.26 | 35.5 | 35.5 | 35.52 | 35.56 | 35.53 | +0.16 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ALBERTDAVD are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about ALBERTDAVD
What is the ALBERTDAVD share price?
ALBERTDAVD (ALBERTDAVD) last closed at ₹757.00, down 0.38% on the day. Its 52-week range is ₹587.05 to ₹898.60.
What is the market cap of ALBERTDAVD?
ALBERTDAVD has a market capitalisation of about ₹430 crore. Its price-to-earnings ratio is 14.8.
How are ALBERTDAVD's latest results?
Promoter holding was 62.24% in Sep 2026, up 0.11 points over 8 quarters.
Who owns ALBERTDAVD?
As of Sep 2026, shareholding was: Promoter 62.24%, FII 0.6%, DII 1.64%, Public 35.53%.
How many mutual funds hold ALBERTDAVD?
0 mutual fund schemes held ALBERTDAVD in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 25 Jul 2025 · Final Dividend - Rs. 5
- 02 Aug 2024 · Final Dividend - Rs. 11.5
- 03 Aug 2023 · Dividend - Rs. 9
- 01 Aug 2022 · Dividend - Rs. 9
- 06 Sep 2021 · Dividend - Rs. 6
- 13 Mar 2020 · Interim Dividend - Rs. 7
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.